FDA Clears Sentient’s Tixel for Treatment of Periorbital Wrinkles
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Findings suggest that tools designed to elicit patient values can improve communication and support African American women in choosing between implant-based and autologous reconstruction after mastectomy.